跳至主要内容
临床试验/NL-OMON54610
NL-OMON54610招募中不适用

Treating PTSD in patients with co-occurring substance use disorders: a randomized controlled trial to compare the efficacy of different types and timing of treatment. - Treatment Of PTSD and Addiction (TOP-A)

Arkin (Amsterdam)0 个研究点目标入组 205 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
205

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • In order to be eligible to participate in this study, a subject must meet all
  • of the following criteria:
  • - age 18 years or older;
  • - substance use disorder(s) according to the Diagnostic and Statistical Manual
  • of Mental Disorders 5 criteria (DSM-5; American Psychiatric Association, 2013)
  • with a primary diagnosis involving one of the following substances: alcohol,
  • cannabis, cocaine (snorting) amphetamine, benzodiazepine, opioid.
  • - posttraumatic stress disorder according to the DSM-5 criteria;
  • - sufficient understanding of the Dutch language.

排除标准

  • A potential subject who meets any of the following criteria will be excluded
  • from participation in this study: - acute psychotic disorder; - mental
  • retardation or cognitive impairment (estimated IQ<70); - current physical or
  • sexual abuse or death threats; - suicidal behavior; (A suicide attempt during
  • the past 3 month or acute suicidal ideations according to the MINI) - life
  • threatening self-mutilation; - homelessness. - involvement in a compensation
  • case or legal procedures concerning admission or stay in the Netherlands -
  • involvement in legal procedures regarding the index trauma - engagement in any
  • other current PTSD treatment Current amendement: - Explicit indication at the
  • baseline IC that they do not wish to be approached for future research

研究者

发起方
Arkin (Amsterdam)

相似试验

Treating PTSD in patients with co-occurring... | 临床试验